1. Home
  2. TNON vs CDIO Comparison

TNON vs CDIO Comparison

Compare TNON & CDIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TNON
  • CDIO
  • Stock Information
  • Founded
  • TNON 2012
  • CDIO 2017
  • Country
  • TNON United States
  • CDIO United States
  • Employees
  • TNON N/A
  • CDIO N/A
  • Industry
  • TNON Medical Specialities
  • CDIO Biotechnology: Commercial Physical & Biological Resarch
  • Sector
  • TNON Health Care
  • CDIO Health Care
  • Exchange
  • TNON Nasdaq
  • CDIO Nasdaq
  • Market Cap
  • TNON 6.9M
  • CDIO 6.3M
  • IPO Year
  • TNON 2022
  • CDIO N/A
  • Fundamental
  • Price
  • TNON $0.99
  • CDIO $3.78
  • Analyst Decision
  • TNON Strong Buy
  • CDIO Buy
  • Analyst Count
  • TNON 3
  • CDIO 1
  • Target Price
  • TNON $11.67
  • CDIO $60.00
  • AVG Volume (30 Days)
  • TNON 174.9K
  • CDIO 47.9K
  • Earning Date
  • TNON 08-12-2025
  • CDIO 08-11-2025
  • Dividend Yield
  • TNON N/A
  • CDIO N/A
  • EPS Growth
  • TNON N/A
  • CDIO N/A
  • EPS
  • TNON N/A
  • CDIO N/A
  • Revenue
  • TNON $3,284,000.00
  • CDIO $19,902.00
  • Revenue This Year
  • TNON $46.26
  • CDIO $1,434.82
  • Revenue Next Year
  • TNON $58.02
  • CDIO $4,661.91
  • P/E Ratio
  • TNON N/A
  • CDIO N/A
  • Revenue Growth
  • TNON 2.18
  • CDIO N/A
  • 52 Week Low
  • TNON $0.85
  • CDIO $3.22
  • 52 Week High
  • TNON $15.79
  • CDIO $53.10
  • Technical
  • Relative Strength Index (RSI)
  • TNON 46.84
  • CDIO 39.09
  • Support Level
  • TNON $0.88
  • CDIO $3.65
  • Resistance Level
  • TNON $0.95
  • CDIO $3.73
  • Average True Range (ATR)
  • TNON 0.06
  • CDIO 0.23
  • MACD
  • TNON 0.02
  • CDIO 0.17
  • Stochastic Oscillator
  • TNON 57.90
  • CDIO 51.31

About TNON Tenon Medical Inc.

Tenon Medical Inc is a medical device company that has developed a novel, minimally invasive approach to the sacroiliac joint (the SI Joint) using a single, robust, titanium implant for the treatment of the common types of SI Joint disorders that cause lower back pain. The Company is focused on three commercial opportunities; Primary SI Joint procedures, Revision procedures of failed SI Joint implants, and SI Joint fusion adjunct to a spine fusion construct. The company derives the majority of its revenue from sales of The Catamaran System to a limited number of clinicians.

About CDIO Cardio Diagnostics Holdings Inc. Common stock

Cardio Diagnostics Holdings Inc is a medical technology company focused on developing and commercializing epigenetics-based clinical tests for cardiovascular diseases. The company offers three AI-powered solutions for the risk assessment, detection, management, and monitoring of coronary heart diseases. These solutions are Epi+Gen CHD, a symptomatic CHD risk assessment clinical blood test targeting CHD events; PrecisionCHD, an integrated epigenetic-genetic clinical blood test for the detection of coronary heart disease; and Actionable Clinical Intelligence, a platform coupled to the Epi+Gen CHD and PrecisionCHD tests that provide personalized insights by linking the epigenetic and genetic biomarkers evaluated by these tests to the drivers of coronary heart disease.

Share on Social Networks: